Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
5
×
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
deals
pfizer
alzheimer's disease
bayer
cancer
clinical trials
merck
What
roundup
5
×
bio
cancer
drug
amid
annual
attention
biotech
bombast
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
ahead
alzheimer’s
ambien
american
approved
asco
assessed
attendees
camp’s
cash
chicago
city
clinical
combinations
communities
Language
unset
Current search:
investing
×
roundup
×
" seattle blog main "
×
" nonalcoholic steatohepatitis "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More